The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antimicrobial Peptides Market Research Report 2025
Synopsis
The global market for Antimicrobial Peptides was valued at US$ 5.5 million in the year 2024 and is projected to reach a revised size of US$ 8 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.
By region, North America had the highest share of sales, at about 35%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antimicrobial Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antimicrobial Peptides.
The Antimicrobial Peptides market size, estimations, and forecasts are provided in terms of sales volume (Mg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antimicrobial Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antimicrobial Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology
Segment by Type
Plant Antimicrobial Peptides
Microbial Antimicrobial Peptides
Animal Antimicrobial Peptides
Segment by Application
Pharmaceuticals
Feed Additives
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antimicrobial Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antimicrobial Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global market for Antimicrobial Peptides was valued at US$ 5.5 million in the year 2024 and is projected to reach a revised size of US$ 8 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.
By region, North America had the highest share of sales, at about 35%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antimicrobial Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antimicrobial Peptides.
The Antimicrobial Peptides market size, estimations, and forecasts are provided in terms of sales volume (Mg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antimicrobial Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antimicrobial Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology
Segment by Type
Plant Antimicrobial Peptides
Microbial Antimicrobial Peptides
Animal Antimicrobial Peptides
Segment by Application
Pharmaceuticals
Feed Additives
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antimicrobial Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antimicrobial Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Antimicrobial Peptides Market Overview
1.1 Product Definition
1.2 Antimicrobial Peptides by Type
1.2.1 Global Antimicrobial Peptides Market Value Comparison by Type (2024 VS 2031)
1.2.2 Plant Antimicrobial Peptides
1.2.3 Microbial Antimicrobial Peptides
1.2.4 Animal Antimicrobial Peptides
1.3 Antimicrobial Peptides by Application
1.3.1 Global Antimicrobial Peptides Market Value by Application (2024 VS 2031)
1.3.2 Pharmaceuticals
1.3.3 Feed Additives
1.3.4 Others
1.4 Global Antimicrobial Peptides Market Size Estimates and Forecasts
1.4.1 Global Antimicrobial Peptides Revenue 2020-2031
1.4.2 Global Antimicrobial Peptides Sales 2020-2031
1.4.3 Global Antimicrobial Peptides Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Antimicrobial Peptides Market Competition by Manufacturers
2.1 Global Antimicrobial Peptides Sales Market Share by Manufacturers (2020-2025)
2.2 Global Antimicrobial Peptides Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Antimicrobial Peptides Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Antimicrobial Peptides, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antimicrobial Peptides, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antimicrobial Peptides, Product Type & Application
2.7 Global Key Manufacturers of Antimicrobial Peptides, Date of Enter into This Industry
2.8 Global Antimicrobial Peptides Market Competitive Situation and Trends
2.8.1 Global Antimicrobial Peptides Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antimicrobial Peptides Players Market Share by Revenue
2.8.3 Global Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antimicrobial Peptides Market Scenario by Region
3.1 Global Antimicrobial Peptides Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Antimicrobial Peptides Sales by Region: 2020-2031
3.2.1 Global Antimicrobial Peptides Sales by Region: 2020-2025
3.2.2 Global Antimicrobial Peptides Sales by Region: 2026-2031
3.3 Global Antimicrobial Peptides Revenue by Region: 2020-2031
3.3.1 Global Antimicrobial Peptides Revenue by Region: 2020-2025
3.3.2 Global Antimicrobial Peptides Revenue by Region: 2026-2031
3.4 North America Antimicrobial Peptides Market Facts & Figures by Country
3.4.1 North America Antimicrobial Peptides Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Antimicrobial Peptides Sales by Country (2020-2031)
3.4.3 North America Antimicrobial Peptides Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antimicrobial Peptides Market Facts & Figures by Country
3.5.1 Europe Antimicrobial Peptides Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Antimicrobial Peptides Sales by Country (2020-2031)
3.5.3 Europe Antimicrobial Peptides Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antimicrobial Peptides Market Facts & Figures by Region
3.6.1 Asia Pacific Antimicrobial Peptides Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Antimicrobial Peptides Sales by Region (2020-2031)
3.6.3 Asia Pacific Antimicrobial Peptides Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antimicrobial Peptides Market Facts & Figures by Country
3.7.1 Latin America Antimicrobial Peptides Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Antimicrobial Peptides Sales by Country (2020-2031)
3.7.3 Latin America Antimicrobial Peptides Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antimicrobial Peptides Market Facts & Figures by Country
3.8.1 Middle East and Africa Antimicrobial Peptides Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Antimicrobial Peptides Sales by Country (2020-2031)
3.8.3 Middle East and Africa Antimicrobial Peptides Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antimicrobial Peptides Sales by Type (2020-2031)
4.1.1 Global Antimicrobial Peptides Sales by Type (2020-2025)
4.1.2 Global Antimicrobial Peptides Sales by Type (2026-2031)
4.1.3 Global Antimicrobial Peptides Sales Market Share by Type (2020-2031)
4.2 Global Antimicrobial Peptides Revenue by Type (2020-2031)
4.2.1 Global Antimicrobial Peptides Revenue by Type (2020-2025)
4.2.2 Global Antimicrobial Peptides Revenue by Type (2026-2031)
4.2.3 Global Antimicrobial Peptides Revenue Market Share by Type (2020-2031)
4.3 Global Antimicrobial Peptides Price by Type (2020-2031)
5 Segment by Application
5.1 Global Antimicrobial Peptides Sales by Application (2020-2031)
5.1.1 Global Antimicrobial Peptides Sales by Application (2020-2025)
5.1.2 Global Antimicrobial Peptides Sales by Application (2026-2031)
5.1.3 Global Antimicrobial Peptides Sales Market Share by Application (2020-2031)
5.2 Global Antimicrobial Peptides Revenue by Application (2020-2031)
5.2.1 Global Antimicrobial Peptides Revenue by Application (2020-2025)
5.2.2 Global Antimicrobial Peptides Revenue by Application (2026-2031)
5.2.3 Global Antimicrobial Peptides Revenue Market Share by Application (2020-2031)
5.3 Global Antimicrobial Peptides Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AnaSpec
6.1.1 AnaSpec Company Information
6.1.2 AnaSpec Description and Business Overview
6.1.3 AnaSpec Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AnaSpec Antimicrobial Peptides Product Portfolio
6.1.5 AnaSpec Recent Developments/Updates
6.2 AMP Biotech
6.2.1 AMP Biotech Company Information
6.2.2 AMP Biotech Description and Business Overview
6.2.3 AMP Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AMP Biotech Antimicrobial Peptides Product Portfolio
6.2.5 AMP Biotech Recent Developments/Updates
6.3 Phoenix Biotech
6.3.1 Phoenix Biotech Company Information
6.3.2 Phoenix Biotech Description and Business Overview
6.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Phoenix Biotech Antimicrobial Peptides Product Portfolio
6.3.5 Phoenix Biotech Recent Developments/Updates
6.4 Novabiotics
6.4.1 Novabiotics Company Information
6.4.2 Novabiotics Description and Business Overview
6.4.3 Novabiotics Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novabiotics Antimicrobial Peptides Product Portfolio
6.4.5 Novabiotics Recent Developments/Updates
6.5 Chinese Peptide
6.5.1 Chinese Peptide Company Information
6.5.2 Chinese Peptide Description and Business Overview
6.5.3 Chinese Peptide Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Chinese Peptide Antimicrobial Peptides Product Portfolio
6.5.5 Chinese Peptide Recent Developments/Updates
6.6 Ontores
6.6.1 Ontores Company Information
6.6.2 Ontores Description and Business Overview
6.6.3 Ontores Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Ontores Antimicrobial Peptides Product Portfolio
6.6.5 Ontores Recent Developments/Updates
6.7 GenScript
6.7.1 GenScript Company Information
6.7.2 GenScript Description and Business Overview
6.7.3 GenScript Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GenScript Antimicrobial Peptides Product Portfolio
6.7.5 GenScript Recent Developments/Updates
6.8 Hycult Biotech
6.8.1 Hycult Biotech Company Information
6.8.2 Hycult Biotech Description and Business Overview
6.8.3 Hycult Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hycult Biotech Antimicrobial Peptides Product Portfolio
6.8.5 Hycult Biotech Recent Developments/Updates
6.9 Sunsmile
6.9.1 Sunsmile Company Information
6.9.2 Sunsmile Description and Business Overview
6.9.3 Sunsmile Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sunsmile Antimicrobial Peptides Product Portfolio
6.9.5 Sunsmile Recent Developments/Updates
6.10 Ruixing Biotechnology
6.10.1 Ruixing Biotechnology Company Information
6.10.2 Ruixing Biotechnology Description and Business Overview
6.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ruixing Biotechnology Antimicrobial Peptides Product Portfolio
6.10.5 Ruixing Biotechnology Recent Developments/Updates
6.11 Zhongnong Yingtai Biotechnology
6.11.1 Zhongnong Yingtai Biotechnology Company Information
6.11.2 Zhongnong Yingtai Biotechnology Description and Business Overview
6.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Portfolio
6.11.5 Zhongnong Yingtai Biotechnology Recent Developments/Updates
6.12 Glam Technology
6.12.1 Glam Technology Company Information
6.12.2 Glam Technology Description and Business Overview
6.12.3 Glam Technology Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Glam Technology Antimicrobial Peptides Product Portfolio
6.12.5 Glam Technology Recent Developments/Updates
6.13 ProteLight Pharmaceutical & Biotechnology
6.13.1 ProteLight Pharmaceutical & Biotechnology Company Information
6.13.2 ProteLight Pharmaceutical & Biotechnology Description and Business Overview
6.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
6.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Portfolio
6.13.5 ProteLight Pharmaceutical & Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antimicrobial Peptides Industry Chain Analysis
7.2 Antimicrobial Peptides Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antimicrobial Peptides Production Mode & Process Analysis
7.4 Antimicrobial Peptides Sales and Marketing
7.4.1 Antimicrobial Peptides Sales Channels
7.4.2 Antimicrobial Peptides Distributors
7.5 Antimicrobial Peptides Customer Analysis
8 Antimicrobial Peptides Market Dynamics
8.1 Antimicrobial Peptides Industry Trends
8.2 Antimicrobial Peptides Market Drivers
8.3 Antimicrobial Peptides Market Challenges
8.4 Antimicrobial Peptides Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Antimicrobial Peptides Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Antimicrobial Peptides Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Antimicrobial Peptides Market Competitive Situation by Manufacturers in 2024
Table 4. Global Antimicrobial Peptides Sales (Mg) of Key Manufacturers (2020-2025)
Table 5. Global Antimicrobial Peptides Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Antimicrobial Peptides Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Antimicrobial Peptides Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Antimicrobial Peptides Average Price (US$/Mg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Antimicrobial Peptides, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Antimicrobial Peptides, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Antimicrobial Peptides, Product Type & Application
Table 12. Global Key Manufacturers of Antimicrobial Peptides, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antimicrobial Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Peptides as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antimicrobial Peptides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Antimicrobial Peptides Sales by Region (2020-2025) & (Mg)
Table 18. Global Antimicrobial Peptides Sales Market Share by Region (2020-2025)
Table 19. Global Antimicrobial Peptides Sales by Region (2026-2031) & (Mg)
Table 20. Global Antimicrobial Peptides Sales Market Share by Region (2026-2031)
Table 21. Global Antimicrobial Peptides Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Antimicrobial Peptides Revenue Market Share by Region (2020-2025)
Table 23. Global Antimicrobial Peptides Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Antimicrobial Peptides Revenue Market Share by Region (2026-2031)
Table 25. North America Antimicrobial Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Antimicrobial Peptides Sales by Country (2020-2025) & (Mg)
Table 27. North America Antimicrobial Peptides Sales by Country (2026-2031) & (Mg)
Table 28. North America Antimicrobial Peptides Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Antimicrobial Peptides Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Antimicrobial Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Antimicrobial Peptides Sales by Country (2020-2025) & (Mg)
Table 32. Europe Antimicrobial Peptides Sales by Country (2026-2031) & (Mg)
Table 33. Europe Antimicrobial Peptides Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Antimicrobial Peptides Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Antimicrobial Peptides Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Antimicrobial Peptides Sales by Region (2020-2025) & (Mg)
Table 37. Asia Pacific Antimicrobial Peptides Sales by Region (2026-2031) & (Mg)
Table 38. Asia Pacific Antimicrobial Peptides Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Antimicrobial Peptides Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Antimicrobial Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Antimicrobial Peptides Sales by Country (2020-2025) & (Mg)
Table 42. Latin America Antimicrobial Peptides Sales by Country (2026-2031) & (Mg)
Table 43. Latin America Antimicrobial Peptides Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Antimicrobial Peptides Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Antimicrobial Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Antimicrobial Peptides Sales by Country (2020-2025) & (Mg)
Table 47. Middle East and Africa Antimicrobial Peptides Sales by Country (2026-2031) & (Mg)
Table 48. Middle East and Africa Antimicrobial Peptides Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Antimicrobial Peptides Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Antimicrobial Peptides Sales (Mg) by Type (2020-2025)
Table 51. Global Antimicrobial Peptides Sales (Mg) by Type (2026-2031)
Table 52. Global Antimicrobial Peptides Sales Market Share by Type (2020-2025)
Table 53. Global Antimicrobial Peptides Sales Market Share by Type (2026-2031)
Table 54. Global Antimicrobial Peptides Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Antimicrobial Peptides Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Antimicrobial Peptides Revenue Market Share by Type (2020-2025)
Table 57. Global Antimicrobial Peptides Revenue Market Share by Type (2026-2031)
Table 58. Global Antimicrobial Peptides Price (US$/Mg) by Type (2020-2025)
Table 59. Global Antimicrobial Peptides Price (US$/Mg) by Type (2026-2031)
Table 60. Global Antimicrobial Peptides Sales (Mg) by Application (2020-2025)
Table 61. Global Antimicrobial Peptides Sales (Mg) by Application (2026-2031)
Table 62. Global Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Table 63. Global Antimicrobial Peptides Sales Market Share by Application (2026-2031)
Table 64. Global Antimicrobial Peptides Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Antimicrobial Peptides Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Antimicrobial Peptides Revenue Market Share by Application (2020-2025)
Table 67. Global Antimicrobial Peptides Revenue Market Share by Application (2026-2031)
Table 68. Global Antimicrobial Peptides Price (US$/Mg) by Application (2020-2025)
Table 69. Global Antimicrobial Peptides Price (US$/Mg) by Application (2026-2031)
Table 70. AnaSpec Company Information
Table 71. AnaSpec Description and Business Overview
Table 72. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 73. AnaSpec Antimicrobial Peptides Product
Table 74. AnaSpec Recent Developments/Updates
Table 75. AMP Biotech Company Information
Table 76. AMP Biotech Description and Business Overview
Table 77. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 78. AMP Biotech Antimicrobial Peptides Product
Table 79. AMP Biotech Recent Developments/Updates
Table 80. Phoenix Biotech Company Information
Table 81. Phoenix Biotech Description and Business Overview
Table 82. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 83. Phoenix Biotech Antimicrobial Peptides Product
Table 84. Phoenix Biotech Recent Developments/Updates
Table 85. Novabiotics Company Information
Table 86. Novabiotics Description and Business Overview
Table 87. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 88. Novabiotics Antimicrobial Peptides Product
Table 89. Novabiotics Recent Developments/Updates
Table 90. Chinese Peptide Company Information
Table 91. Chinese Peptide Description and Business Overview
Table 92. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 93. Chinese Peptide Antimicrobial Peptides Product
Table 94. Chinese Peptide Recent Developments/Updates
Table 95. Ontores Company Information
Table 96. Ontores Description and Business Overview
Table 97. Ontores Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 98. Ontores Antimicrobial Peptides Product
Table 99. Ontores Recent Developments/Updates
Table 100. GenScript Company Information
Table 101. GenScript Description and Business Overview
Table 102. GenScript Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 103. GenScript Antimicrobial Peptides Product
Table 104. GenScript Recent Developments/Updates
Table 105. Hycult Biotech Company Information
Table 106. Hycult Biotech Description and Business Overview
Table 107. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 108. Hycult Biotech Antimicrobial Peptides Product
Table 109. Hycult Biotech Recent Developments/Updates
Table 110. Sunsmile Company Information
Table 111. Sunsmile Description and Business Overview
Table 112. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 113. Sunsmile Antimicrobial Peptides Product
Table 114. Sunsmile Recent Developments/Updates
Table 115. Ruixing Biotechnology Company Information
Table 116. Ruixing Biotechnology Description and Business Overview
Table 117. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 118. Ruixing Biotechnology Antimicrobial Peptides Product
Table 119. Ruixing Biotechnology Recent Developments/Updates
Table 120. Zhongnong Yingtai Biotechnology Company Information
Table 121. Zhongnong Yingtai Biotechnology Description and Business Overview
Table 122. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 123. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product
Table 124. Zhongnong Yingtai Biotechnology Recent Developments/Updates
Table 125. Glam Technology Company Information
Table 126. Glam Technology Description and Business Overview
Table 127. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 128. Glam Technology Antimicrobial Peptides Product
Table 129. Glam Technology Recent Developments/Updates
Table 130. ProteLight Pharmaceutical & Biotechnology Company Information
Table 131. ProteLight Pharmaceutical & Biotechnology Description and Business Overview
Table 132. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 133. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product
Table 134. ProteLight Pharmaceutical & Biotechnology Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Antimicrobial Peptides Distributors List
Table 138. Antimicrobial Peptides Customers List
Table 139. Antimicrobial Peptides Market Trends
Table 140. Antimicrobial Peptides Market Drivers
Table 141. Antimicrobial Peptides Market Challenges
Table 142. Antimicrobial Peptides Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Antimicrobial Peptides
Figure 2. Global Antimicrobial Peptides Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antimicrobial Peptides Market Share by Type: 2024 & 2031
Figure 4. Plant Antimicrobial Peptides Product Picture
Figure 5. Microbial Antimicrobial Peptides Product Picture
Figure 6. Animal Antimicrobial Peptides Product Picture
Figure 7. Global Antimicrobial Peptides Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Antimicrobial Peptides Market Share by Application: 2024 & 2031
Figure 9. Pharmaceuticals
Figure 10. Feed Additives
Figure 11. Others
Figure 12. Global Antimicrobial Peptides Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Antimicrobial Peptides Market Size (2020-2031) & (US$ Million)
Figure 14. Global Antimicrobial Peptides Sales (2020-2031) & (Mg)
Figure 15. Global Antimicrobial Peptides Average Price (US$/Mg) & (2020-2031)
Figure 16. Antimicrobial Peptides Report Years Considered
Figure 17. Antimicrobial Peptides Sales Share by Manufacturers in 2024
Figure 18. Global Antimicrobial Peptides Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Antimicrobial Peptides Players: Market Share by Revenue in Antimicrobial Peptides in 2024
Figure 20. Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Antimicrobial Peptides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Antimicrobial Peptides Sales Market Share by Country (2020-2031)
Figure 23. North America Antimicrobial Peptides Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Antimicrobial Peptides Sales Market Share by Country (2020-2031)
Figure 27. Europe Antimicrobial Peptides Revenue Market Share by Country (2020-2031)
Figure 28. Germany Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Antimicrobial Peptides Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Antimicrobial Peptides Revenue Market Share by Region (2020-2031)
Figure 35. China Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Antimicrobial Peptides Sales Market Share by Country (2020-2031)
Figure 46. Latin America Antimicrobial Peptides Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Antimicrobial Peptides Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Antimicrobial Peptides Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Antimicrobial Peptides Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Antimicrobial Peptides by Type (2020-2031)
Figure 56. Global Revenue Market Share of Antimicrobial Peptides by Type (2020-2031)
Figure 57. Global Antimicrobial Peptides Price (US$/Mg) by Type (2020-2031)
Figure 58. Global Sales Market Share of Antimicrobial Peptides by Application (2020-2031)
Figure 59. Global Revenue Market Share of Antimicrobial Peptides by Application (2020-2031)
Figure 60. Global Antimicrobial Peptides Price (US$/Mg) by Application (2020-2031)
Figure 61. Antimicrobial Peptides Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
